Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
- NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_assertion description "[Because these tumours tend to be less sensitive than other types of GTD to chemotherapy, the most successful regimen to date has been with EMA/CO or EMA/EP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
- NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_assertion evidence source_evidence_literature NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
- NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_assertion SIO_000772 14614893 NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
- NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_assertion wasDerivedFrom befree-2016 NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
- NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_assertion wasGeneratedBy ECO_0000203 NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.
- befree-2016 importedOn "2016-02-19" NP420563.RAVVhAG09iNEcdMR_Hqq2DNM54Q9n1wGteGjpliqD7M-8130_provenance.